Sign in
Download Opera News App

STOCK INVESTMENT

Wedbush Weighs in on Immunic, Inc.’s Q1 2021 Earnings (NASDAQ:IMUX)

Wedbush Weighs in on Immunic, Inc.’s Q1 2021 Earnings (NASDAQ:IMUX)

Immunic, Inc. (NASDAQ:IMUX) – Stock analysts at Wedbush reduced their Q1 2021 EPS estimates for shares of Immunic in a research report issued on Monday, March 1st. Wedbush analyst L. Moussatos now expects that the company will post earnings per share of ($0.64) for the quarter, down from their previous estimate...

Read Full Story
IMUX Immunic Inc L. Moussatos Wedbush

Top News

DISEASE PREVENTION AND TREATMENT

US recommends 'pause' for J&J vaccine over clot reports

apnews.com
US recommends 'pause' for J&J vaccine over clot reports

DISEASE PREVENTION AND TREATMENT

US recommends 'pause' for J&J vaccine over clot reports

apnews.com

MURDER

Knoxville high school shooting leaves 'multiple' people hurt, including cop: police say

foxnews.com
Knoxville high school shooting leaves 'multiple' people hurt, including cop: police say

MURDER

Knoxville high school shooting leaves 'multiple' people hurt, including cop: police say

foxnews.com

comments

Load app to read more comments